An interventional study of PPKAY (brief intervention) and Standard Booster in Alcohol Use Disorder, Injury Traumatic and Trauma, sponsored by Duke University. Completed at 1 site in Tanzania. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Duke University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Alcohol use is rapidly increasing in low- and middle-income countries, where it is inexpensive, readily available, poorly regulated, and there are few resources devoted to promoting safe alcohol use. A Brief Intervention based on a motivational interviewing framework has been shown to reduce alcohol use and alcohol-related harms. The investigators have translated and adapted a Brief Intervention for alcohol to the Tanzanian context and Swahili language called "Punguza Pombe Kwa Afya Yako (PPKAY)/ Reduce Alcohol for Your Health." This project will evaluate this intervention in injury patients presenting for care at the Kilimanjaro Christian Medical Center in Moshi, Tanzania. By using innovative adaptive clinical trial methods, the investigators will expedite the development of the most effective way to integrate this intervention into clinical care. By the end of this project, investigators will have identified the most effective brief intervention components and be able to characterize the intervention's effect overall. Additionally, investigators will standardize adaptive trial methods to revolutionize the science of clinical trials for behavioral sciences in low-resource settings.
1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.
This study's enrollment of 673 is above the median of 88 across 1,433 interventional studies indexed under Alcoholism.
Browse Alcoholism studies →Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
No prevention or educational information verbally or written coinciding with current usual care
One-time, 15-minute, nurse-led motivational interview discussing safe drinking behaviors, and negotiating change in alcohol use
Behavioral: PPKAY (brief intervention)
One-time, 15-minute, nurse-led motivational interview discussing safe drinking behaviors, and negotiating change in alcohol use. Weekly standard text booster until final follow-up (e.g., "Reducing your alcohol intake to less than 4 drinks per day reduces your risk of alcohol-related consequences")
Behavioral: PPKAY (brief intervention) · Behavioral: Standard Booster
One-time, 15-minute, nurse-led motivational interview discussing safe drinking behaviors, and negotiating change in alcohol use Weekly personalized text booster until final follow-up (e.g., "Remember to reduce your alcohol less than 4 drinks to achieve your goal of… \[being a better husband\].")
Behavioral: PPKAY (brief intervention) · Behavioral: Personalized Booster
PPKAY is a nurse-administered, one-on-one, 15-minute brief intervention (BI) for alcohol use using FRAMES motivational interviewing techniques. The BI is a four-step discussion: 1) Raise the Subject of Alcohol, 2) Provide Feedback, 3) Enhance Motivation 4) Negotiate and Advice.
After discharge from the hospital, a standard motivational text message will be sent to their cell phone twice monthly for the duration of the study. In a rotating fashion, one of four standard motivational texts translated into Swahili will be sent to their cell phones.
After discharge from the hospital, a personalized motivational text message will be sent to participant cell phones twice monthly for the duration of the study. In a rotating fashion, one of four personalized motivational texts will be sent to their cell phones. Personalized texts will be created with the content obtained from the motivational interview sessions. At each session, the research nurse conducting the intervention will record four messages based on the content of the session to be sent as the Personalized Booster.
Number of Binge Drinking Days (Previous 4 Weeks)
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Frequency of Alcohol Use (Previous 2 Weeks)
Reported as the number of drinking days during the past two weeks.
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Quantity of Alcohol Use (Previous 2 Weeks)
Reported as the number of drinks consumed during the past two weeks.
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Alcohol-related Harms Measured by the Drinker Inventory of Consequences (DrInC)
The Drinker Inventory of Consequences (DrInC) is a fifty-item questionnaire with scores ranging from 0 to 150, where a higher number indicates a greater number of negative consequences.
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
AUDIT (Alcohol Use Disorder Identification Test) Score
Alcohol use disorder as measured by AUDIT (alcohol use disorder identification test) score. AUDIT is a ten-item tool, with scores ranging from 0 to 40, where a higher score indicates higher risk alcohol use.
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
Depression as Measured by Patient Health Questionnaire 9 (PHQ-9)
The PHQ-9 consists of 9 simple questions evaluating core symptoms of depression over the past two weeks. Each item is rated on a scale of 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating greater symptom severity.
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 24 months
| Milestone | Stage I: Usual Care | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Stage II: PPKAY |
|---|---|---|---|---|
| Started | 171 | 203 | 210 | 0 |
| Completed | 129 | 131 | 110 | 0 |
| Not completed | 42 | 72 | 100 | 0 |
| Milestone | Stage I: Usual Care | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Stage II: PPKAY |
|---|---|---|---|---|
| Started | 0 | 0 | 0 | 89 |
| Completed | 0 | 0 | 0 | 1 |
| Not completed | 0 | 0 | 0 | 88 |
| days | Usual Care | PPKAY | PPKAY With Standard Booster | PPKAY With Personalized Booster |
|---|---|---|---|---|
| Baseline | 3.7 ± 7.0 | 4.3 ± 7.6 | 4.2 ± 7.3 | 4.1 ± 6.7 |
| 3 months | 0.9 ± 3.8 | 1.2 ± 4.9 | 0.6 ± 3.0 | 0.3 ± 2.3 |
| 6 months | 1.3 ± 4.7 | 0.5 ± 1.4 | 0.7 ± 2.9 | 0.4 ± 2.5 |
| 9 months | 1.5 ± 4.5 | 0.6 ± 1.5 | 0.8 ± 3.8 | 0.3 ± 1.3 |
| 12 months | 1.6 ± 4.3 | 0.8 ± 2.0 | 1.1 ± 4.3 | 0.3 ± 1.4 |
| 24 months | 2.5 ± 6.8 | — | 0.7 ± 2.9 | 0.2 ± 1.0 |
Reported as the number of drinking days during the past two weeks.
| days | Usual Care | PPKAY | PPKAY With Standard Booster | PPKAY With Personalized Booster |
|---|---|---|---|---|
| Baseline | 4.0 ± 3.9 | 4.8 ± 4.3 | 4.1 ± 3.8 | 3.9 ± 3.6 |
| 3 months | 1.3 ± 3.2 | 1.4 ± 3.2 | 0.7 ± 2.0 | 0.6 ± 2.0 |
| 6 months | 1.6 ± 3.2 | 1.0 ± 2.2 | 0.8 ± 1.9 | 0.6 ± 2.0 |
| 9 months | 1.7 ± 3.5 | 0.7 ± 1.2 | 1.0 ± 2.5 | 0.8 ± 2.2 |
| 12 months | 1.8 ± 3.4 | 1.5 ± 2.4 | 1.1 ± 2.7 | 0.8 ± 2.3 |
| 24 months | 2.2 ± 4.1 | — | 1.2 ± 2.4 | 1.0 ± 2.6 |
Reported as the number of drinks consumed during the past two weeks.
| drinks | Usual Care | PPKAY | PPKAY With Standard Booster | PPKAY With Personalized Booster |
|---|---|---|---|---|
| Baseline | 22.9 ± 35.6 | 26.6 ± 37.8 | 22.7 ± 34.7 | 21.4 ± 35.6 |
| 3 months | 5.0 ± 13.0 | 10.2 ± 31.5 | 3.7 ± 16.7 | 2.2 ± 9.9 |
| 6 months | 6.5 ± 15.8 | 4.3 ± 10.9 | 3.4 ± 9.7 | 2.2 ± 8.5 |
| 9 months | 7.3 ± 19.9 | 3.4 ± 6.8 | 5.4 ± 17.6 | 3.3 ± 10.4 |
| 12 months | 9.7 ± 28.2 | 6.3 ± 10.9 | 5.8 ± 17.3 | 2.3 ± 7.2 |
| 24 months | 12.3 ± 30.5 | — | 4.9 ± 11.5 | 2.6 ± 7.3 |
The Drinker Inventory of Consequences (DrInC) is a fifty-item questionnaire with scores ranging from 0 to 150, where a higher number indicates a greater number of negative consequences.
| score on a scale | Usual Care | PPKAY | PPKAY With Standard Booster | PPKAY With Personalized Booster |
|---|---|---|---|---|
| Baseline | 14.4 ± 16.3 | 15.7 ± 15.6 | 13.2 ± 15.4 | 13.4 ± 7.3 |
| 3 months | 2.8 ± 7.8 | 6.7 ± 8.6 | 2.0 ± 7.5 | 4.0 ± 4.4 |
| 6 months | 5.5 ± 11.4 | 6.5 ± 10.1 | 2.9 ± 7.0 | 4.4 ± 4.1 |
| 9 months | 3.7 ± 8.9 | 4.2 ± 5.9 | 5.1 ± 11.6 | 5.1 ± 5.0 |
| 12 months | 5.9 ± 11.2 | 8.3 ± 20.3 | 4.5 ± 9.6 | 4.6 ± 5.1 |
| 24 months | 8.8 ± 12.5 | — | 8.0 ± 14.3 | 3.6 ± 3.9 |
Alcohol use disorder as measured by AUDIT (alcohol use disorder identification test) score. AUDIT is a ten-item tool, with scores ranging from 0 to 40, where a higher score indicates higher risk alcohol use.
| score on a scale | Usual Care | PPKAY | PPKAY With Standard Booster | PPKAY With Personalized Booster |
|---|---|---|---|---|
| Baseline | 13.3 ± 7.1 | 11.7 ± 7.0 | 13.1 ± 7.7 | 13.4 ± 7.3 |
| 3 months | 3.9 ± 4.1 | 5.2 ± 4.5 | 4.1 ± 4.3 | 4.0 ± 4.4 |
| 6 months | 5.3 ± 5.8 | 5.0 ± 5.1 | 4.4 ± 4.7 | 4.4 ± 4.1 |
| 9 months | 5.0 ± 4.9 | 5.7 ± 4.9 | 5.0 ± 4.9 | 5.1 ± 5.0 |
| 12 months | 5.1 ± 5.2 | 5.7 ± 5.8 | 4.6 ± 4.8 | 4.6 ± 5.1 |
| 24 months | 5.4 ± 5.5 | — | 4.8 ± 5.1 | 3.6 ± 3.9 |
The PHQ-9 consists of 9 simple questions evaluating core symptoms of depression over the past two weeks. Each item is rated on a scale of 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating greater symptom severity.
| score on a scale | Usual Care | PPKAY | PPKAY With Standard Booster | PPKAY With Personalized Booster |
|---|---|---|---|---|
| Baseline | 3.1 ± 4.0 | 3.0 ± 4.5 | 3.0 ± 3.7 | 3.8 ± 4.4 |
| 3 months | 3.4 ± 4.2 | 3.4 ± 4.0 | 3.4 ± 4.0 | 4.1 ± 4.4 |
| 6 months | 3.9 ± 5.0 | 2.5 ± 3.6 | 2.7 ± 3.1 | 3.4 ± 3.7 |
| 9 months | 2.7 ± 3.3 | 2.2 ± 4.2 | 2.4 ± 3.3 | 2.9 ± 3.6 |
| 12 months | 3.3 ± 4.1 | 1.4 ± 2.4 | 2.8 ± 4.0 | 3.1 ± 3.9 |
| 24 months | 2.6 ± 3.2 | — | 2.2 ± 2.8 | 2.3 ± 3.5 |
Collected over Up to 24 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Usual Care | 5/171 (2.9%) | 0/171 (0%) | 0/171 (0%) |
| PPKAY | 1/89 (1.1%) | 0/89 (0%) | 0/89 (0%) |
| PPKAY With Standard Booster | 4/203 (2%) | 0/203 (0%) | 0/203 (0%) |
| PPKAY With Personalized Booster | 5/210 (2.4%) | 0/210 (0%) | 0/210 (0%) |
Stage II only included the PPKAY-only participants.
| Age, Continuous(years) | Stage I: Usual Care | Stage II: PPKAY | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Total |
|---|---|---|---|---|---|
| Mean | 36 ± 12 | 37 ± 14 | 36 ± 12 | 37 ± 13 | 36 ± 13 |
| Sex: Female, Male(Participants) | Stage I: Usual Care | Stage II: PPKAY | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Total |
|---|---|---|---|---|---|
| Female | 9 | 8 | 11 | 15 | 43 |
| Male | 162 | 81 | 192 | 195 | 630 |
| Ethnicity (NIH/OMB)(Participants) | Stage I: Usual Care | Stage II: PPKAY | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Total |
|---|---|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 | 0 | 0 |
| Not Hispanic or Latino | 171 | 89 | 203 | 210 | 673 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Stage I: Usual Care | Stage II: PPKAY | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Total |
|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 171 | 89 | 202 | 210 | 672 |
| White | 0 | 0 | 1 | 0 | 1 |
| More than one race | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 |
| Region of Enrollment(Participants) | Stage I: Usual Care | Stage II: PPKAY | Stage I: PPKAY With Standard Booster | Stage I: PPKAY With Personalized Booster | Total |
|---|---|---|---|---|---|
| Tanzania | 171 | 89 | 203 | 210 | 673 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Oct 2020 to primary completion in May 2025, 55 months.
Results were first posted in Nov 2026, 1 year 5 months after primary completion.
Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's 55 months is above that.
Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.